Grant: Engage Grants Program
Dalhousie University
$25,000.00
Towards genomics-assisted breeding of medical marijuana
FY 2015-16
Summary
BedroCan is a leading licensed producer of medical marijuana in Canada. Its R&D department has identified a
set of compounds in marijuana that influence consumer preference and medicinal effect. Their aim is to breed
novel marijuana strains with specific profiles of these compounds. But this task is challenging: performing
detailed chemical tests of thousands of offspring in their breeding programme is prohibitively time consuming
and expensive. They have a clear breeding target but cannot achieve it on their own.
The proposed project will foster a new partnership between BedroCan and the Myles lab that will develop the
first genomics-assisted breeding toolkit for marijuana. By the end of the project timeline, we will identify a
novel set of genetic markers that BedroCan's breeders can use to identify improved strains with the desired
chemical profiles at the seedling stage, without the need to grow them to maturity and perform expensive
chemical tests. Not only will this accelerate BedroCan's breeding programme, but the new knowledge from
this project will generate valuable intellectual property for BedroCan. Furthermore, the aim is to then further
develop the resulting IP into a commercial genetic test to be licensed to others, providing a potential novel
source of revenue for the company. The discoveries from this project will not only lend legitimacy to a rapidly
growing, multi-billion dollar industry in need of scientific input, but it will also accelerate the improvement of
marijuana strains that attain higher consumer acceptance and better medical outcomes for Canadians.
Program
Engage Grants Program
Recipient
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
491543-2015
Name nom
Myles, Sean
Department département
Plant and Animal Sciences (Faculty of Agriculture)
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5000
Research subject group en
Genetics
Research subject group fr
Génétique
Research subject en
Genetics
Research subject fr
Génétique
Partie
1
Nb partie
1
Application title
Towards genomics-assisted breeding of medical marijuana
Keyword
NSERC
Application summary
BedroCan is a leading licensed producer of medical marijuana in Canada. Its R&D department has identified a
set of compounds in marijuana that influence consumer preference and medicinal effect. Their aim is to breed
novel marijuana strains with specific profiles of these compounds. But this task is challenging: performing
detailed chemical tests of thousands of offspring in their breeding programme is prohibitively time consuming
and expensive. They have a clear breeding target but cannot achieve it on their own.
The proposed project will foster a new partnership between BedroCan and the Myles lab that will develop the
first genomics-assisted breeding toolkit for marijuana. By the end of the project timeline, we will identify a
novel set of genetic markers that BedroCan's breeders can use to identify improved strains with the desired
chemical profiles at the seedling stage, without the need to grow them to maturity and perform expensive
chemical tests. Not only will this accelerate BedroCan's breeding programme, but the new knowledge from
this project will generate valuable intellectual property for BedroCan. Furthermore, the aim is to then further
develop the resulting IP into a commercial genetic test to be licensed to others, providing a potential novel
source of revenue for the company. The discoveries from this project will not only lend legitimacy to a rapidly
growing, multi-billion dollar industry in need of scientific input, but it will also accelerate the improvement of
marijuana strains that attain higher consumer acceptance and better medical outcomes for Canadians.